Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Physiol Biochem ; 125(1): 25-29, 2019 Feb.
Article in English | MEDLINE | ID: mdl-29390872

ABSTRACT

The aim of the present experiment was to investigate the possible antiarrhythmic effects of dalfampridine in ouabain-induced arrhythmia in rats. Twenty-four male rats including the control and dalfampridine-incubated (100 µM to 10 mM) ouabain-stimulated (40 µM) groups were used. After induction of anesthesia, the atria were isolated and the time of onset of arrhythmia and asystole were recorded. The contractile force of atria was also measured. Dalfampridine at concentration of 1 mM significantly postponed the onset of arrhythmia and asystole compared to control group (p ≤ .05). Ouabain significantly increased the atrial beating rate in control group (p ≤ .05), while pretreatment of isolated atria with dalfampridine reversed this effect. Incubation of isolated atria with ouabain did not alter the contractile force in both control- and dalfampridine-treated groups (p > .05). It is concluded that dalfampridine might possess antiarrhythmic properties in reducing the atrial arrhythmias.


Subject(s)
4-Aminopyridine/pharmacology , Anti-Arrhythmia Agents/pharmacology , Arrhythmias, Cardiac/chemically induced , Arrhythmias, Cardiac/drug therapy , Heart Atria/drug effects , Ouabain/adverse effects , Potassium Channel Blockers/pharmacology , 4-Aminopyridine/therapeutic use , Animals , Anti-Arrhythmia Agents/therapeutic use , Arrhythmias, Cardiac/pathology , Arrhythmias, Cardiac/physiopathology , Dose-Response Relationship, Drug , Heart Atria/pathology , Heart Atria/physiopathology , Male , Potassium Channel Blockers/therapeutic use , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...